Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cyclerion Therapeutics (CYCN) Return on Assets (2019 - 2025)

Cyclerion Therapeutics has reported Return on Assets over the past 7 years, most recently at 0.42% for Q3 2025.

  • Quarterly results put Return on Assets at 0.42% for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was 0.42% (changed N/A YoY), and the annual figure for FY2023 was 0.47%, up 113.0%.
  • Return on Assets for Q3 2025 was 0.42% at Cyclerion Therapeutics, down from 0.33% in the prior quarter.
  • Over the last five years, Return on Assets for CYCN hit a ceiling of 1.26% in Q2 2024 and a floor of 1.77% in Q1 2023.
  • Median Return on Assets over the past 5 years was 0.8% (2021), compared with a mean of 0.57%.
  • Biggest five-year swings in Return on Assets: skyrocketed 267bps in 2024 and later plummeted -158bps in 2025.
  • Cyclerion Therapeutics' Return on Assets stood at 0.87% in 2021, then tumbled by -89bps to 1.64% in 2022, then surged by 131bps to 0.51% in 2023, then surged by 145bps to 1.26% in 2024, then plummeted by -133bps to 0.42% in 2025.
  • The last three reported values for Return on Assets were 0.42% (Q3 2025), 0.33% (Q2 2025), and 0.15% (Q1 2025) per Business Quant data.